Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Power needs for artificial intelligence and cloud computing are expanding so rapidly that some data center campuses may use ...

Microsoft stock was lagging its tech peers on Friday as investors reacted to news the company is facing a broad inquiry from ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

We recently compiled a list of the 15 Trending AI Stocks on Latest Ratings and News. In this article, we are going to take a ...

IMAX Corp.’s shares have climbed 71.2% in 2024, and analyst firm Wedbush sees more upside ahead for the high-end movie-theater operator.

Trump previously vowed to end federal electric vehicle tax credits, which are worth up to $7,500 for new zero-emission ...

Apple Inc.’s skeptics and bears have missed the last more than $1 trillion upward move in the stock by overlooking three key dynamics behind the story, Wedbush analysts said Friday. Apple has an ...

It’s hard to believe, but it was just two years ago that OpenAI released ChatGPT to the world – and showed us all just how ...